Tech Company Financing Transactions

Catabasis Pharmaceuticals Funding Round

Advanced Technology Ventures, Clarus and MedImmune Ventures invested in a $32.4 million Series B funding round for Catabasis Pharmaceuticals. The funding round was announced by the company on 11/14/2013.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

1 Kendall Sq. B14202
Cambridge, MA 02139
USA

Phone

(617) 349-1971

Website

www.catabasis.com

Email Address

[email protected]

Overview

At Catabasis (NASDAQ: CATB) we are dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases. We have assembled a team of highly motivated and experienced scientists who are committed to improving the lives of patients.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jill Milne

        

Chief Financial Officer

Ian Sanderson

        

Chief Medical Officer

Joanne Donovan

        

Browse more venture capital transactions:

Prev: 11/14/2013: Genapsys venture capital transaction
Next: 11/14/2013: nexgrid venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary